BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3492158)

  • 1. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
    Cullen MR; Kominsky JR; Rossman MD; Cherniack MG; Rankin JA; Balmes JR; Kern JA; Daniele RP; Palmer L; Naegel GP
    Am Rev Respir Dis; 1987 Jan; 135(1):201-8. PubMed ID: 3492158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3.
    Kreiss K; Mroz MM; Newman LS; Martyny J; Zhen B
    Am J Ind Med; 1996 Jul; 30(1):16-25. PubMed ID: 8837677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom.
    Johnson JS; Foote K; McClean M; Cogbill G
    Appl Occup Environ Hyg; 2001 May; 16(5):619-30. PubMed ID: 11370940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
    McCawley MA; Kent MS; Berakis MT
    Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beryllium aerosol characteristics in the magnesium and aluminum transformation industry in Quebec: a comparison of four different sampling methodologies.
    Dufresne A; Dion C; Viau S; Cloutier Y; Perrault G
    J Occup Environ Hyg; 2009 Nov; 6(11):687-97. PubMed ID: 19757293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
    Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
    Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on the choice of exposure metrics as risk indicators.
    Wambach PF
    J Occup Environ Hyg; 2007 Oct; 4(10):D103-4; author reply D104-8. PubMed ID: 17763067
    [No Abstract]   [Full Text] [Related]  

  • 11. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
    Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
    Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Summary of historical beryllium uses and airborne concentration levels at Los Alamos National Laboratory.
    Stefaniak AB; Weaver VM; Cadorette M; Puckett LG; Schwartz BS; Wiggs LD; Jankowski MD; Breysse PN
    Appl Occup Environ Hyg; 2003 Sep; 18(9):708-15. PubMed ID: 12909539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoidosis and chronic beryllium disease: similarities and differences.
    Mayer AS; Hamzeh N; Maier LA
    Semin Respir Crit Care Med; 2014 Jun; 35(3):316-29. PubMed ID: 25007084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
    Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR
    J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium.
    Newman LS; Kreiss K
    Am Rev Respir Dis; 1992 May; 145(5):1212-4. PubMed ID: 1586067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical analysis of airborne beryllium concentrations at a copper beryllium machining facility (1964-2000).
    McAtee BL; Donovan EP; Gaffney SH; Frede W; Knutsen JS; Paustenbach DJ
    Ann Occup Hyg; 2009 Jun; 53(4):373-82. PubMed ID: 19383942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
    Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
    Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric test for beryllium sensitivity.
    Milovanova TN; Popma SH; Cherian S; Moore JS; Rossman MD
    Cytometry B Clin Cytom; 2004 Jul; 60(1):23-30. PubMed ID: 15221866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beryllium: a modern industrial hazard.
    Kreiss K; Day GA; Schuler CR
    Annu Rev Public Health; 2007; 28():259-77. PubMed ID: 17094767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Cluster of Beryllium Sensitization Traced to the Presence of Beryllium in Concrete Dust.
    Frye BC; Quartucci C; Rakete S; Grubanovic A; Höhne K; Mangold F; Gieré R; Müller-Quernheim J; Zissel G
    Chest; 2021 Mar; 159(3):1084-1093. PubMed ID: 32926872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.